![Arun Swaminathan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Arun Swaminathan
Algemeen Directeur bij COYA THERAPEUTICS, INC.
Vermogen: 65 200 $ op 30-11-2024
Profiel
Arun Swaminathan is the founder of Lynkogen, Inc. He is currently the Chief Executive Officer & Director at Coya Therapeutics, Inc. He previously worked as the Director-Worldwide Brand at Bristol Myers Squibb Co. and as the Head-Marketing at Labcorp Drug Development, Inc. Before that, Arun served as the Chief Business Officer at Actinium Pharmaceuticals, Inc. from 2022 to 2023, and as the Chief Business Officer & Senior Vice President at Alteogen, Inc. from 2018 to 2021.
Dr. Swaminathan holds a doctorate degree from the University of Pittsburgh and an undergraduate degree from the University of Madras.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
COYA THERAPEUTICS, INC.
0.06% | 13-11-2024 | 10 000 ( 0.06% ) | 65 200 $ | 30-11-2024 |
Laatste nieuws over Arun Swaminathan
Actieve functies van Arun Swaminathan
| Bedrijven | Functie | Begin |
|---|---|---|
| COYA THERAPEUTICS, INC. | Algemeen Directeur | 01-11-2024 |
Eerdere bekende functies van Arun Swaminathan
| Bedrijven | Functie | Einde |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-03-2023 |
| ALTEOGEN INC. | Corporate Officer/Principal | 01-09-2021 |
| COVANCE INC. | Verkoop & Marketing | - |
| Lynkogen, Inc. | Algemeen Directeur | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Opleiding van Arun Swaminathan
| University of Pittsburgh | Doctorate Degree |
| University of Madras | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| ALTEOGEN INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| COYA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
| Lynkogen, Inc. | |
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
